Literature DB >> 6487325

Micro-analysis for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts.

S Vadhanavikit, M Morishita, G A Duff, K Folkers.   

Abstract

A micro-analysis was designed for determining the levels of coenzyme Q10 (CoQ10) in specimens of ca. 500 nanograms of myocardial tissues. The prime steps included acetone extraction, purification by thin-layer chromatography, and HPLC. CoQ11 was the internal standard. This methodology was successful for human endomyocardial biopsies from cardiac patients before and after therapy with CoQ10 and has now been used for canine and bovine tissues. The mean canine CoQ10 level from six specimens from the left ventricle (l.v.) of a single animal is 0.99 +/- 0.06 micrograms/mg/d.w. The mean levels of the tissues from nine animals is 1.04 +/- 0.17 (l.v.) and 1.11 +/- 0.16 (r.v.). The mean bovine level from seven animals was 0.48 +/- 0.12 (l.v.) and 0.68 +/- 0.06 (r.v.).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487325     DOI: 10.1016/s0006-291x(84)80255-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Muscle ubiquinone in healthy physically active males.

Authors:  J Karlsson; L Lin; C Sylvén; E Jansson
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

2.  Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.

Authors:  Anne Louise Mortensen; Franklin Rosenfeldt; Krzysztof J Filipiak
Journal:  Cardiol J       Date:  2019-03-05       Impact factor: 2.737

3.  Lovastatin decreases coenzyme Q levels in rats.

Authors:  R A Willis; K Folkers; J L Tucker; C Q Ye; L J Xia; H Tamagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10.

Authors:  K Folkers; S Vadhanavikit; S A Mortensen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

5.  Muscle ubiquinone in male effort angina patients.

Authors:  J Karlsson; L Lin; S Gunnes; C Sylvén; H Aström
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

6.  Coenzyme Q10 and key enzyme activities in papillary muscle related to left ventricle function in mitral valve disease.

Authors:  J Karlsson; C Sylvén; E Jansson; K Böök; K Muratsu; K Folkers
Journal:  Mol Cell Biochem       Date:  1988-11       Impact factor: 3.396

7.  Heart muscle ubiquinone and plasma antioxidants following cardiac transplantation.

Authors:  J Karlsson; J Liska; S Gunnes; B Koul; B Semb; H Aström; B Diamant; K Folkers
Journal:  Clin Investig       Date:  1993

8.  Ubiquinone and alpha-tocopherol in plasma; means of translocation or depot.

Authors:  J Karlsson; B Diamant; H Theorell; K Folkers
Journal:  Clin Investig       Date:  1993

9.  Coenzyme Q10 protects ischemic myocardium in an open-chest swine model.

Authors:  D Atar; S A Mortensen; H Flachs; W R Herzog
Journal:  Clin Investig       Date:  1993

Review 10.  Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone).

Authors:  S A Mortensen
Journal:  Clin Investig       Date:  1993
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.